Hantaviruses: A tale of two hemispheres

Panminerva Medica

Volumn 45, Issue 1, 2003, Pages 43-51

  Khan, A ^a,b   Khan, A S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Hantavirus; Hantavirus infections, diagnosis; Hantavirus infections, epidemiology; Hantavirus pulmonary syndrome; Hemorrhagic fever with renal syndrome

Indexed keywords

CORTICOSTEROID; DOBUTAMINE; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; RIBAVIRIN;

AEROSOL; ASIA; CARDIOGENIC SHOCK; CHINA; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; ECOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; EXCRETION; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; LUNG EDEMA; NONHUMAN; NUCLEIC ACID ANALYSIS; PATHOGENESIS; PATIENT CARE; PUUMALA VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RODENT; SEOUL VIRUS; SERODIAGNOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; VIRUS PARTICLE; VIRUS TRANSMISSION; WESTERN BLOTTING; WESTERN HEMISPHERE; ANIMAL; EPIDEMIC; HEALTH; PATHOPHYSIOLOGY; PREVENTIVE MEDICINE;

ANIMALS; DISEASE OUTBREAKS; HANTAVIRUS INFECTIONS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; PREVENTIVE MEDICINE; WORLD HEALTH;

EID: 0038486987     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Faulde M, Sobe D, Kimmig P, Scharninghausen J. Renal failure and hantavirus infection in Europe. Nephrol Dial Transplant 2000;15:751-3.
2. Lee HW, Lee PW, Johnson KM. Isolation of etiologic agent of Korean hemorrhagic fever. J Infect Dis 1978;137:298-308.
3. McKee KT, LeDuc JW, Peters CJ. Hantaviruses. In: Belshe RB, editor. Textbook of human virology. 2nd edition. St. Louis: Mosby Year Book, 1991:615-32.
4. Centers for Disease Control and Prevention. Outbreak of acute illness - Southwestern United States, 1993. MMWR Morb Mortal Wkly Rep 1993;42:421-4.
5. Young JC, Mills JN, Enria DA, Dolan NE, Khan AS, Ksiazek TG. New world hantaviruses. Br Med Bull 1998;54:659-73.
6. Lee HW. Epidemiology and pathogenesis of hemorrhagic fever with renal syndrome. In: Elliot RM, editor. The Bunyaviridae. New York: Plenum Press, 1996:253-67.
7. Meisel H, Lundkvist A, Gantzer K, Bar W, Sibold C, Kruger DH. First cases of infection with hantavirus Dobrava in Germany. Eur J Clin Microbiol Infect Dis 1998;17:884-92.
8. Plyusnin A, Nemirov K, Apekina N, Plyusnina A, Lundkvist A, Vaheri A. Dobrava hantavirus in Russia. Lancet 1999;353:207.
9. Plyusnin A, Vapalathi O, Vasilenko V, Henttonen H, Vaheri A. Dobrava hantavirus infections in Estonia: does the virus exist throughout Europe? Lancet 1997;349:1369-70.
10. Sibold C, Ulrich R, Labuda M, Lundkvist A, Martens H, Schutt M et al. Dobrava hantavirus causes hemorrhagic fever with renal syndrome in Central Europe and is carried by two different Apodemus mice species. J Med Virol 2001;63:158-67.
11. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietila K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994;26:7-13.
12. Settergen B, Ahlm C, Alexeyev O, Billheden J, Stegmayr, B. Pathogenetic and clinical aspects of the renal involvement in hemorrhagic fever with renal syndrome. Ren Fail 1997;19:1-14.
13. Nichol ST, Ksiazek TG, Rollin PE, Peters CJ. Hantavirus pulmonary syndrome and newly described hantaviruses in the United States. In: Elliott RM, editor. The Bunyaviridae. New York: Plenum Press, 1996:269-80.
14. Ksiazek TG, Peters CJ, Rollin PE, Zaki SR, Nichol ST, Spiropoulou CF et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995;52:117-23.
15. Rollin PE, Ksiazek TG, Elliot LH, Ravkov EV, Martin ML, Morzunov S et al. Isolation of Black Creek Canal virus: a new hantavirus from Sigmodon Hispidus in Florida. J Med Virol 1995;46:35-9.
16. Khan AS, Spiropoulou CF, Morzunov S, Zaki SR, Kohn MA, Nawas SR et al. A fatal illness associated with a new hantavirus in Louisiana. J Med Virol 1995;46:281-6.
17. Williams RJ, Bryan RT, Mills JN, Palma RE, Vera I, De Valasquez F et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg 1997;57:274-82.
18. Padula PJ, Colavecchia SB, Martinez VP, Figueroa RE, Peters CJ, Khan AS et al. Genetic diversity, distribution and serologic features of hantavirus infection in 5 countries in South America. J Clin Micrbiol 2000;38:3029-35.
19. Vincent MJ, Quiroz E, Gracia F, Sanchez AJ, Ksiazek TG, Kitsutani PT et al. Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reserviors. Virology 2000;277:14-9.
20. Padula P, Edelstein A, Miguel SDL, Lopez NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome (HPS) outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998;241:323-30.
21. Toro J, Vega JD, Khan AS, Mills JN, Padula P, Terry W et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 1998;4:687-94.
22. Wells RM, Sosa Estani S, Yadon Z, Enria D, Padula P, Pini N et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg Infect Dis 1997;3:171-4.
23. Nuti M, Amaddeo D, Crovatto M, Ghionni A, Polato D, Lillini E et al. Infections in an Alpine environment: antibodies to hantaviruses, leptospira, rickettsiae, and Borrelia burgdorferi in defined Italian populations. Am J Trop Med Hyg 1993;48:20-5.
24. Glass GE, Watson AJ, LeDuc JW, Childs JE. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron 1994;68:48-51.
25. Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield LM et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993. Arch Pathol Lab Med 1996;120:134-9.
26. Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners Region of the United States in the wake of the 1997-1998 El Nino-Southern Oscillation. J Infect Dis 2000;181:1569-73.
27. Mills JN, Ksiazek TG, Ellis BA, Rollin PE, Nichol ST, Yates TL et al. Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg 1997;56:273-84.
28. Armstrong LR, Zaki SR, Goldoft MJ, Todd RL, Khan AS, Khabbaz RF et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infected structures [letter]. J Infect Dis 1995;172:1166.
29. Childs JE, Krebs JW, Ksiazek TG, Maupin GO, Gage KL, Rollin PE et al. A household-based, case-control study of environmental factors associated with hantavirus pulmonary syndrome in the southwestern United States. Am J Trop Med Hyg 1995;52:393-7.
30. th edition. Pennsylvania: W. B. Saunders Company, 2000:288-93.
31. Armstrong LR, Khabbaz RF, Childs JE, Rollin PE, Martin ML, Clarke M et al. Occupational exposure to hantavirus in mammalogists and rodent workers [Abstract]. Am J Trop Med Hyg 1994;51(Suppl):94.
32. Zeitz PS, Graber JM, Voorhees RA, Kiosk C, Shands LA, Ksiazek TG et al. Assessment of occupational risk for hantaviruses infection in Arizona and New Mexico. J Occup Environ Med 1997;39:463-7.
33. Khan AS, Young J. Hantavirus pulmonary syndrome: at the crossroads. Curr Opin Infect Dis 2001;14:205-9.
34. Pini N, Resa A, Laime G, Lecot G, Ksiazek T, Levis S et al. Hantavirus infection in children in Argentina. Emerg Infect Dis 1998;4:85-7.
35. Ferrer JF, Jonosson CB, Esteban E, Galligan D, Basombrio MA, Peralta-Ramos M et al. High Prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg 1998;59:438-44.
36. Cosgriff TM. Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 1991;13:97-107.
37. Cosgriff TM, Lewis RM. Mechanism of disease in hemorrhagic fever with renal syndrome. Kidney Intl 1991;40:72-9.
38. Duchin JS, Koster Ft, Peters CJ, Simpson GL, Tempest B, Zaki SR et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-55.
39. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996;24:252-8.
40. Kitsutani PT, Denton RW, Fritz CL, Murray RA, Todd RL, Pape WJ et al. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis 1999;5:701-5.
41. Hjelle B, Goade D, Torrez-Martinez N, Lang-Williams M, Kim J, Harris RL et al. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 1996;23:495-500.
42. Goade DE, Nofchissey RA, Lanzi R, Roldan C, James D, Garlin A et al. Long term fatigue, proteinuria and pulmonary sequelae following HPS. Paper presented at the Fifth International Conference on Hemorrhagic fever with renal syndrome, hantavirus pulmonary syndrome, and hantaviruses. Veyrier-du-Lac, France, June 2001.
43. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K et al. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 1995;146:552-79.
44. Nolte KB, Feddersen RM, Foucar K, Zaki Sr, Koster FT, Madar D. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995;26:110-20.
45. Ketai LH, Williamson MR, Telepak RJ, Levy H, Koster FT, Nolte KB et al. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 1994;191:665-8.
46. Ketai LH, Kelsey CA, Jordan K, Levin DL, Sullivan LM, Williamson MR et al. Distinguishing hantavirus pulmonary syndrome from acute respiratory syndrome by chest radiography: are there different radiographic manifestations of increased alveolar permeability? J Thorac Imag 1998;13:172-7.
47. Mackow ER, Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 2001;256:91-115.
48. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 1999;179:295-302.
49. Wimer BM. Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections. Cancer Biother Radiopharm 1998;13:193-207.
50. + cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virol 1997;238(2):380-90.
51. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000;182:43-8.
52. Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001;289:6-14.
53. Amoura Z, Papo T, Ninet J, Hatron PY, Guillaumie J, Piette AM et al. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med 1997;103:514-9.
54. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu Zo et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119-27.
55. Crowley MR, Katz RW, Kessler R, Simpson SQ, Levy H, Hallin GW et al. Successful treatment of adults with severe hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 1998;26:409-14.
56. Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antivir Ther 1999;4:211-9.